The recruitment of blood-borne fibrocytes implicated in tissue fibrosis is also CCR2 responsive (Moore et al, 2005) and could theoretically play a role in the beneficial effects of CCR2 inhibition observed in our study. The gene discussed is CCR2; the disease is fibrosis.